e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung positron emission tomography with FDG in patients with haematological malignancies and acute respiratory failure
Pineton De Chambrun Marc, Lemiale Virginie, Azoulay Élie
Source:
Eur Respir J 2016; 47: 324-327
Journal Issue:
January
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Pineton De Chambrun Marc, Lemiale Virginie, Azoulay Élie. Lung positron emission tomography with FDG in patients with haematological malignancies and acute respiratory failure. Eur Respir J 2016; 47: 324-327
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lane-hamilton syndrome and CCF: a fatal association
Imaging of complicated pneumonia: what is new?
Imaging of eosinophilic lung disease
Related content which might interest you:
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 227s
Year: 2001
(18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002
Prognostic value of fluorine-18 fluorodeoxyglucose (18-FDG) positron emission tomography imaging in patients with non-small cell lung carcinoma
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Positron emission tomography (PET) using
18
F-fluorodeoxyglucose (
18
FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways
Source: Eur Respir J 2001; 18: Suppl. 33, 18s
Year: 2001
The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245
Year: 2004
Quantitative
18
F-fluorodeoxyglucose positron emission tomography/computed tomography to assess pulmonary inflammation in COPD
Source: ERJ Open Res, 7 (3) 00699-2020; 10.1183/23120541.00699-2020
Year: 2021
Positron emission tomography in the diagnostic work-up of screening-detected lung nodules
Source: Eur Respir J 2015; 45: 501-510
Year: 2015
Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
Source: Eur Respir J 2009; 33: 201-212
Year: 2009
The use of SPECT in preoperative assessment of patients with lung cancer
Source: Eur Respir J 2004; 24: 258-262
Year: 2004
Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer
Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer
Year: 2008
Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer
Source: Eur Respir J 2007; 29: 995-1002
Year: 2007
The relation of fluorine-18 fluorodeoxyglucose positron emission tomography imaging to chemosensitivity for platinum doublet chemotherapy in patients with advanced stage non small cell lung cancer
Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer
Year: 2009
Positron emission tomography (PET) and computed tomography (CT) in the assessment of the mediastinum for patients with presumed or established lung cancer
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008
Imaging the inflammatory activity of sarcoidosis
Source: Eur Respir J 2013; 41: 743-751
Year: 2013
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Source: Eur Respir J 2001; 17: 802-820
Year: 2001
Value of positron emission tomography parameters for the prognosis of small-cell lung carcinoma
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
Imaging in lung cancer: positron emission tomography scan
Source: Eur Respir J 2002; 19: 49S-60S
Year: 2002
Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET)
Source: Eur Respir J 2001; 18: Suppl. 33, 396s
Year: 2001
Accuracy of positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) in diagnosis of recurrence of lung cancer after curative first-line therapy: visual and semiquantitative PET analysis
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept